Company News
ClearPoint Neuro Secures Canadian Navigation License
ClearPoint Neuro (NASDAQ:CLPT) obtained a Health Canada Medical Device License for its Neuro Navigation System on 21‑Apr‑2026.
Approval covers both MRI‑guidance and iCT‑guidance workflows, complementi
